Volume 10 - Issue 12 - December 2013
Feature
Case Series
11/27/2013
Caroline Clezar, MD; Fabrizzio Souza, MD; Nicolle Cassola, MD; Caroline Benze, MD; Andre Milani, MD; Felipe Nasser, PhD; Breno Boueri Affonso, PhD, MD; Jorge Amorim, PhD; Fausto Miranda, Jr., PhD
New drug-eluting balloon technologies offer the hope of significant reductions of such problems, enhancing the results of angioplasty while, at the same time, providing the opportunity for avoidance of a permanent metal stent implant.
New drug-eluting balloon technologies offer the hope of significant reductions of such problems, enhancing the results of angioplasty while, at the same time, providing the opportunity for avoidance of a permanent metal stent implant.
New drug-eluting balloon...
11/27/2013
Vascular Disease Management
Clinical Review
11/27/2013
Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM
Distal protection is protecting the kidney from debris during percutaneous renal intervention with the use of embolic protection devices distal to the lesion.
Distal protection is protecting the kidney from debris during percutaneous renal intervention with the use of embolic protection devices distal to the lesion.
Distal protection is protecting...
11/27/2013
Vascular Disease Management
Case Report
11/27/2013
Asif Serajian, DO; Teja Gundala, MD
The authors discuss possible etiologies, potential methods of prevention, and viable documented techniques of successfully resolving a coronary catheter that becomes kinked.
The authors discuss possible etiologies, potential methods of prevention, and viable documented techniques of successfully resolving a coronary catheter that becomes kinked.
The authors discuss possible...
11/27/2013
Vascular Disease Management
Insights
Interview
11/27/2013
VDM spoke with John Laird, MD, about the recent US Food and Drug Administration approval of the Complete SE stent for new indications. Dr. Laird served as principal investigator for the Complete SE SFA study, in which 99.6% of stents were...
VDM spoke with John Laird, MD, about the recent US Food and Drug Administration approval of the Complete SE stent for new indications. Dr. Laird served as principal investigator for the Complete SE SFA study, in which 99.6% of stents were...
VDM spoke with John Laird, MD,...
11/27/2013
Vascular Disease Management
Column
Clinical Editor's Corner
11/27/2013
Frank J. Criado, MD
The Heli-FX endoanchor showed technical success in initial results of the ANCHOR registry. Their use will continue to evolve.
The Heli-FX endoanchor showed technical success in initial results of the ANCHOR registry. Their use will continue to evolve.
The Heli-FX endoanchor showed...
11/27/2013
Vascular Disease Management
